Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin